European markets are expected to open in mixed territory Thursday, stumbling lower as President Donald Trump’s tariffs policy upends global trading relations.

Pharmaceutical majors AstraZeneca and GSK have partnered with competitor Takeda and nine suppliers to accelerate the adoption ...

The U.S. Department of Labor has reinstated about 120 employees who were facing termination as part of the Trump ...

Syria's Islamist-led government on Monday said it had completed a military operation against a nascent insurgency by Bashar ...

In January, The Wall Street Journal derided Trump’s threat to impose 25 percent tariffs on Canada and Mexico as the opening ...

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.

Earlier Monday, reports of outages soared to nearly 40,000 over the previous 24 hours. UBS analyst Joseph Spak reduced his first-quarter delivery target to 367,000 vehicles from 437,000. The Big Four ...

Pharma giant Novo Nordisk was among the top performers ... position to overcome domestic opposition when negotiating with Beijing, much like when former U.S. President Richard Nixon reestablished ...